Halifax, Nova Scotia–(Newsfile Corp. – June 24, 2020) – Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: ATURF) (FSE: AHUH) (“Sixth Wave” or the “Company“) is pleased to announce that the Patent Office of the People’s Republic of China has granted the Company a patent for its unique method of metal extraction and purification using molecularly imprinted polymers (the “Patent”).

The Patent expands the Company’s existing patent portfolio. Sixth Wave’s IXOS® technology is one embodiment of the patented IP and selectively binds to target metal ions such as dicyanoaurate, which is the compound produced in the cyanide leaching process of gold extraction. IXOS® has been proven to result in more efficient metal extraction in multiple pilot programs with major mining companies.

“The patent process is typically slow and fraught with negotiation with issuing authorities. While there has been a preponderance of work in the field of molecular science, I am proud of our team and their ability to create practical, and commercially viable new intellectual property using these techniques to solve challenging real-world problems,” said Dr. Jon Gluckman, President and CEO of Sixth Wave.

Sixth Wave is pursuing multiple opportunities to commercialize its IXOS® metals extraction technology. Sixth Wave’s IXOS® technology has demonstrated the ability to deliver an efficient, scalable, environmentally friendly, and lower cost alternative to activated carbon in the gold processing cycle.

About Sixth Wave

Sixth Wave is a development stage nanotechnology company with patented technologies that focus on extraction and detection of target substances at the molecular level using highly specialized molecularly imprinted polymers. The Company is in the process of commercializing its Affinity™ cannabinoid purification system, as well as, IXOS®, a line of extraction polymers for the gold mining industry.

Sixth Wave can design, develop and commercialize molecular imprinted polymer solutions across a broad spectrum of industries. The company is focused on nanotechnology architectures that are highly relevant for detection and separation of viruses, biogenic amines and other pathogens, for which the Company has products at various stages of development.

For more information about Sixth Wave, please visit: www.sixthwave.com.

ON BEHALF OF THE BOARD OF DIRECTORS

“Jon Gluckman“

Jonathan Gluckman, Ph.D., President & CEO

For information, please contact the Company:

Phone: (801) 582-0559
E-mail: [email protected]

Cautionary Notes

This press release includes certain statements that may be deemed “forward-looking statements” including statements regarding the planned features of the MIPs technology. All statements in this release, other than statements of historical facts, that address future events or developments that the Company expects, are forward-looking statements. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance, and actual events or developments may differ materially from those in forward-looking statements. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause the Company’s actual performance and financial results in future periods to differ materially from any projections of future performance or results expressed or implied by such forward-looking statements. In particular, successful development and commercialization of the MIPs technology are subject the risk that the MIPs technology may not prove to be effective or economic at commercial levels of production.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/58499